CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal","$":{"href":"/pharma/astrazeneca-pays-15b-egfr-lung-cancer-drug-zegfrovy-its-spinoff-dizal","hreflang":"en"}}]}

Related Companies

Read the original article

Published by FiercePharma on July 14, 2026 9:42 AM

Read Original